Category Archives: New Mexico Stem Cells

The first step is for you to educate yourself by reading most of this website. Ideally, study everything this website has to offer and only then phone to request a preliminary phone meeting with a physician. A doctor will discuss your situation with you over the phone and answer your initial questions. Not everyone is a candidate. If you are still a candidate after that preliminary phone conference, a formal evaluation visit is scheduled.

Your face to face initial evaluation may require one and a half to two hours of discussion, physical examination, ultrasound imaging, education, and more discussion. A precise list is made of what spots in what structures in your joint need refurbishing. That is explained to you and usually shown to you. If you continue to be a candidate at that point, somewhere around 6 once monthly procedures are usually recommended. All your questions are discussed. If you and the physician are satisfied with this plan, a first procedure is scheduled. Some nutritional supplements are usually prescribed. Certain medicines are prohibited. Instructions are given.

At each monthly procedure, your blood is drawn. Key nutrients are infused back into the same vein via IV. Then you have a snack while your blood is processed in our lab to create a concentrate of your platelets and stem cells. This super cell concentrate is mixed with a specialized local anesthetic. Sometimes additional nerve blocks may be performed. Ultrasound imaging is used by the doctor to see the tiny injection needle inside your body and place the super cell mixture exactly within tears or wear sites in each damaged, degenerated ligament, tendon, and meniscus. It usually takes about 2 to 2.5 hours. You walk out of there, go about your day, and probably feel some soreness that evening and the next day. After 2-3 days of only limited exercise, most people can return to whatever activity and exercise they tolerate.

You grow your own. Thats right, for 3-4 weeks, youll grow your own brand new, teen age repair tissue at the sites where injury and degeneration have aged your joint. The regrowth in any one months crop is partial, so monthly repetition for around 6 months is normally necessary. Usually, you start to feel the difference only late in those months, as new tissue accumulates enough to replace tears and areas of degeneration, gradually stabilizing the joint. As you start to feel better, and your physician sees objective improvement with exam or sonographic imaging, you will likely be instructed to become more active, possibly with referral to physical therapists or other outside experts. Strengthening surrounding muscles in that way will eventually complete the process.

It is now possible to turn back the clock on some joint problems, allowing you to become more active again. Read and study the rest of this website carefully and thoroughly. Then, if youd like, we can discuss at least starting the above described step by step process with you.

Read more here:
NMPM | New Mexico Pain Management

Global Stem Cells Group, Inc.

Miami, FL (PRWEB) November 30, 2013

Bioheart Inc., a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group, Inc. in Cozumel, Mexico. The two companies successfully treated their first congestive heart failure patient at the new clinical site last week, using Biohearts AdipoCell (adipose derived stem cells).

The therapy involved the use of stem cells derived from the patients own fat (adipose tissue) obtained using liposuction. The recovered stem cells were injected into the patients heart with Biohearts MyoCath needle injection catheter which allows for introduction of the cells directly into the heart without invasive surgery.

Rafael Moguel, M.D., Head of the Cardiac Program at the Centro Medico de Cozumel, was the treating interventional cardiologist for the Bioheart therapy procedure.

"Our center is very excited to participate in the cutting edge programs at Bioheart," Moguel says. "We can offer new hope to patients suffering from debilitating diseases by utilizing regenerative medicine, and delivering them non-invasively into the heart."

The MyoCath catheter was introduced using a radial artery approach, the first such documented stem cell case using this delivery method. The benefit of a radial artery approach is that it does not require the patient to lie flat for up to six hours, as in a femoral artery approach. Patients are able to sit up, walk and eat immediately following the procedure, and the risk of internal bleeding is eliminated.

Bioheart and Global Stem Cells Group have designed several different protocols to be utilized at the center in Cozumel, offering treatments to patients for a variety of different indications.

About Bioheart, Inc.:

Bioheart is committed to maintaining its leading position within the cardiovascular sector of the cell technology industry delivering cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions and other issues. Biohearts goals are to cause damaged tissue to be regenerated, when possible, and to improve a patient's quality of life and reduce health care costs and hospitalizations.

Specific to biotechnology, Bioheart is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. Its leading product, MyoCell, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients. For more information on Bioheart, visit http://www.bioheartinc.com, or visit us on Facebook: Bioheart and Twitter @BioheartInc.

About the Global Stem Cell Group

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Groups corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

To learn more about Global Stem Cells Group, Inc., and for investor information, visit the Global Stem Cell Group website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.

Forward-Looking Statements: Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "plan," "expect," "believe," "anticipate," "intend," "could," "would," "estimate," or "continue" or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

The Company is subject to the risks and uncertainties described in its filings with the Securities and Exchange Commission, including the section entitled "Risk Factors" in its Annual Report on Form 10-K for the year ended December 31, 2012, and its Quarterly Report on Form 10-Q for the quarter ended September 31, 2013.

Share article on socal media or email:

The rest is here:
Bioheart, Inc. and Global Stem Cells, Inc. Announce New ...

At Del Prado Stem Cell Center we treat :Diabetes,Osteoarthritis,Parkinsons,Alzheimers disease,Dementia,Rheumatoid Arthritis,Chronic Obstructive disorder,Autoimmune Hepatitis,Macular Degeneration,Lupus,Multiple Sclerosis, Age Management,as well as sports injuries like Golfers, Pitchers and Tennis Elbow, Meniscus Tears, Achilles Tendonitis and more.

Del Prado Stem Cell Center is a bank of stem cells throughout Latin America that has formal recognition and certification of OSAC agency from the government of the United States as an institution that unites all requirements for international patients in stem cell therapy, thanks to the level of professionalism and safety handles, being the only institution in Mexico with that recognition by the United States government.

Treatment provided by Del Prado Stem Cell Center is performed atHospital Del Prado, Tijuanasleading health institutionwith 49 years of experience, offering personalized and humane service. We are very thorough inthe selection and performance ofourdoctors and offer nothing but the best treatment and facilities for Stem Cell Therapy treatment in Tijuana, Mexico.Adult Stem Cell Therapies are completely safe and non-invasive. StemCell therapy is evolvingour modern medical panorama were it can offer patients a completely new alternative to cure degenerative and terminal illnesses.

SIGN UP FOR A FREE CONSULTATION

Del Prado Stem Cell Center in Mexico

A procedure in which cells are taken from a donor (Mesenchymal Stem Cells) and administered to a patient.

Stem Cells in Mexico at Del Prado Hospital

For those patients who are eligible for stem cell disease treatment. Their Stem Cells can be obtained from their own fat tissue for later transplant.

Del Prado Medical Center Offering Stem Cell Therapy and Treatment in Tijuana Mexico

Hospital Del Prado is certified for Stem Cell treatment, certified specialists are on hand which have the training and follow adequate transplant protocol. In any case our specialists are on hand for an evaluation and if your disease has been approved we will immediately enter transplant protocol, which can begin right away in most cases, this is without need for Hospitalization for a prolonged period.

Del Parado Hospital in Tijuana Mexico

You are eligible as long as you have a preapproved illness or physical condition where stem cells have proved to be a clinical benefit in research

IMPORTANT NOTICE For Del Prado Stem Cell Center is very important to inform boththe medical community and society in general that stem cell therapyit may be unsuccessful in some cases or not recommended for all patients.Must never create false expectations without clinical and researchstudies to support the implementation of these treatments.So we suggest you talk to your doctor before receiving treatment.

Original post:
Stem Cells in Mexico | Del Prado Stem Cell Center - Tijuana

Our Clinic Our clinic has been certified by the COFEPRIS, which is Mexico's regulatory health organization and performs the same functions as the FDA in the United States.

We have received countless testimonials from very satisfied patients, and if you're traveling to Mexico from the U.S. to receive treatments, we will provide you with a personal assistant who will translate from Spanish to English, give you medical passes that you can use to cross the border swiftly, transport you to and from the airport and help you find our office and your hotel in Tijuana.

http://progencell.com. ProgenCell offers an alternative stem cell treatment that is safe and effective. ProgenCell is able to use adult stem cells obtained from your own bone marrow and transfer the stem cells to a different part of your body through an IV (similar to blood transfusion). This stem cell therapy treatment can help relieve pain and even cure diseases. Learn how stem cells can help you today.

Get Started

If you would like to schedule an appointment, you can fill out the form on our website, and our representatives will contact you within 24 hours.

Additionally, if you have any questions or need immediate assistance, call our office at 1-888-443-6235. At ProgenCell we specialize in the treatment of different conditions including the following:

Stem Cell Therapy for Rheumatoid Arthritis This autoimmune disease causes inflammation in the body's tissues and organs. The condition can be present for more than five years before the patient recognizes any symptoms, and usually, rheumatoid arthritis affects the joints first. Stem cell therapy may help this condition. Over time, this type of arthritis can disfigure the joints and prevent them from functioning properly.

By injecting stem cells into areas of the body that have been damaged by the condition, the healthy cells will regenerate the old, weakened tissues, and as the new cells divide, their positive effects will increase.

Stem Cell Therapy for Systemic Lupus The immune system of an individual with systemic lupus will attack the person's own cells, and usually, the disease primarily affects the heart, the lungs and the kidneys.

Physicians treat the condition by prescribing medications that suppress the activity of the immune system, such as corticosteroids and cyclophosphamide. Stem cell therapy may help this condition.

Stem Cell Therapy for Fibromyalgia

This condition causes chronic pain in numerous parts of the body, and in addition, patients who have fibromyalgia report that they feel fatigued, have stiff joints, feel numbness and tingling and have trouble swallowing.

According to various studies, the causes of fibromyalgia can be neurological, psychological and environmental, and practitioners usually prescribe medications that increase the patient's levels of serotonin and gamma-aminobutyric acid to treat the condition. Stem cell therapy may help this condition.

Stem Cell Therapy for Asthma

The percentage of the population that has been diagnosed with asthma has doubled between the 1970s and 2013, and a study that was conducted in 2011 indicated that 225 million people worldwide have been diagnosed with asthma.

Asthma is a condition that causes chronic inflammation of the airways. The disease's symptoms include shortness of breath and wheezing, and in addition to inhalers, researchers have recently developed two drugs that provide long-term relief, which are salmeterol and formoterol.

Although stem cells won't cure asthma, they can substantially strengthen the tissues of the airways and reduce the effects of the inflammation.

Stem Cell Therapy for Diabetes

Diabetes is a condition that is caused by a lack of production of insulin by the pancreas or by cells that are resistant to insulin.

The early symptoms include frequent urination and increased levels of thirst and hunger. Furthermore, individuals with diabetes usually experience blurred vision.

One of the disease's complications is diabetic ketoacidosis, which must be treated immediately and can be life-threatening. Other, long-term effects of the condition include rashes on the skin, the weakening of the blood vessels and a feeling of numbness or tingling in the feet.

Stem Cell Therapy for Multiple Sclerosis

The immune system of a person who has multiple sclerosis sporadically attacks the insulation of the cells that are in the brain and the spinal cord.

The symptoms of the disease are only evident when a flare-up occurs. A lack of vitamin D, stress or an infection by the influenza virus can trigger an attack.

Stem Cell Therapy for Parkinson's Disease

This is a degenerative disease of the nervous system, and the primary symptoms of Parkinson's disease are caused by the death of cells that produce dopamine in the midbrain.

Early signs of the condition include the trembling of the hands and the fingers, the shaking of the legs and particularly slow movements.

The condition was officially discovered and classified by James Parkinson in 1817; however, an effective treatment for the disease wasn't developed until the 1960s. Medications that are used to reduce the symptoms of the condition include cabergoline, pergolide and drugs that inhibit the activity of monoamine oxidase.

Injecting healthy stem cells into parts of the body that are affected by the symptoms can exponentially improve the condition of the nerves that the condition has begun to degrade, but the patient must receive injections on a biweekly basis or once per month.

Stem Cell Therapy for Retinitis Pigmentosa

This disease is usually inherited, and if left untreated, the condition's symptoms include blurry vision or blindness.

Over time, the tissue in the eyes of an individual with retinitis pigmentosa will degenerate, and usually, the cones that are within the retina begin to deteriorate first.

Our professionals will inject stem cells that are already developed and are programmed to become photoreceptor cells. The treatment must be administered once per month.

Additionally, several studies have indicated that a daily dosage of 15,000 international units of retinyl palmitate can substantially slow the progression of the disease.

Stem Cell Therapy for Kidney Failure

The symptoms of acute renal failure are weight loss, increased levels of creatinine in the blood, feeling fatigued and low blood pressure.

Long-term kidney failure can cause the patient to have trouble falling asleep, darken the individual's skin and reduce the person's appetite.

Read more:
Stem Cell Therapy in Mexico. You Can Improve Your Life ...

On July 18, 2006, the U.S. Senate convened to vote on a proposed bill (H.R. 810) that would amend the Public Health Service Act and provide federal funding for research on human embryonic stem cells. This bill was passed by the Senate but was later vetoed by President George W. Bush. In the vote, the two New Mexico Senators voted against each other: Democrat Jeff Bingaman was in favor of the bill and Republican Pete Domenici opposed it.

Also in 2006, New Mexico Governor Bill Richardson proposed a budget of $10 million of state funds to be dedicated to supporting stem cell research. The money would build a new research center at the Health Sciences Center of the University of New Mexico campus at Albuquerque (with an allocated $4 million), as well as hire research faculty (using another $4 million) and train graduate students for future careers in stem cell research (with the remaining $2 million). The purpose of using state funds to build the research center as well as to support faculty and students is to circumvent the federal law prohibiting stem cell research with federal funds. States, however, are free to choose their own stances on stem cell research. Governor Richardson was approached by New Mexicos Roman Catholic Bishops, who urged him to reconsider his proposal to use embryonic stem cells.

In January 2008, the U.S. Senate again passed a bill in favor of allowing federal funds to support stem cell research while forbidding human cloning. This bill, 2008 Senate Bill 23, or the Biomedi-cal Research Act, was sponsored by New Mexico Senator John C. Ryan and was supported by Governor Bill Richardson.

At present, within the University of New Mexico Health Sciences Center (UNM HSC), there is a graduate training program in development and stem cell biology. Stem cell-related research focuses on embryonic stem cells in terms of their cell cycle and its regulation and how these regulatory schemes are related to those schemes of cancer cells, as well as neural stem cells and the harnessing of such cells to treat disorders such as Parkinsons disease, Alzheimers disease, and numerous other degenerative disorders. In addition, neural stem cells could be used to treat spinal cord injury patients, and further understanding of these stem cells could shed light on the molecular biology of brain tumors.

Another focus of the research at UNM HSC is on adult human renal stem cells. These cells can be harvested from the adult kidney and studied. Such investigations might lead to customized treatment of chronic kidney failure or other renal diseases. Scientists at UNM HSC also study human blood and bone marrow stem cells.

Another university in New Mexico, the New Mexico State University (NMSU), also recognizes the importance of stem cell research. Although little research that is directly related to stem cells is carried out at NMSU, scientists there are encouraged to stay abreast of the biological science regarding stem cells. In fact, the main Web page of the office of the vice president for research highlights stem cell research breakthroughs in its Global Research News Section. Smaller universities such as the Eastern University of New Mexico and the Western

University of New Mexico do not have the facilities to conduct stem cell research, yet they keep their students and faculty informed through classes and seminars that address stem cell biology.

See the original post here:
New Mexico (Stem Cell) - what-when-how

Albuquerque, New Mexico

Albuquerque is the largest city in the state of New Mexico, United States. It is the county seat of Bernalillo County and is situated in the central part of the state, straddling the Rio Grande. Albuquerque is home to the University of New Mexico (UNM), Kirtland Air Force Base, Sandia National Laboratories, Lovelace Respiratory Research Institute, and Petroglyph National Monument. The Sandia Mountains run along the eastern side of Albuquerque, and the Rio Grande flows through the city, north to south. (Source: http://en.wikipedia.org/wiki/Albuquerque)

* Provider Directory Terms of Use:

The WebMD 'Provider Directory' is provided by WebMD for use by the general public as a quick reference of information about Providers. The Provider Directory is not intended as a tool for verifying the credentials, qualifications, or abilities of any Provider contained therein. Inclusion in the Provider Directory does not imply recommendation or endorsement nor does omission in the Provider Directory imply WebMD disapproval.

You are prohibited from using, downloading, republishing, selling, duplicating, or "scraping" for commercial or any other purpose whatsoever, the Provider Directory or any of the data listings or other information contained therein, in whole or in part, in any medium whatsoever.

The Provider Directory is provided on an "AS-IS" basis. WebMD disclaims all warranties, either express or implied, including but not limited to the implied warranties of merchantability and fitness for particular purpose. Without limiting the foregoing, WebMD does not warrant or represent that the Provider Directory or any part thereof is accurate or complete. You assume full responsibility for the communications with any Provider you contact through the Provider Directory. WebMD shall in no event be liable to you or to anyone for any decision made or action taken by you in the reliance on information provided in the Provider Directory.

The use of WebMD Provider Directory by any entity or individual to verify the credentials of Providers is prohibited. The database of Provider information which drives WebMD Provider Directory does not contain sufficient information with which to verify Provider credentials under the standards of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO), National Committee for Quality Assurance (NCQA) of the Utilization Review Accreditation Committee (URAC).

By using the WebMD Provider Directory, you agree to these Terms and Conditions.

Read more here:
Albuquerque NM Resources - Stem Cells: Get Facts on ...

ORLANDO, Fla. (WOFL FOX 35 ORLANDO) - An Orlando family impacted by ALS is spreading awareness about the need, not only for research, but also assistance to families impacted by the incurable disease today who are being bankrupted by it.

"We tried to do it all by ourselves until we realized that the atrophy and the muscles were just deteriorating. What do we do now? Are we just going to sit back, and get busy dying? We're getting busy living," said Walter Briggs, a former NFL quarterback who dabbled in acting.

He is now a full-time caregiver for his wife, Debra. She was diagnosed with ALS, or Lou Gehrig's Disease, in September of 2012. Shortly thereafter, she left her position as a family case manager.

"It takes a lot out of her every day, every night to just survive," said Walter.

Debra founded Debra's Journey for Life Foundation, Inc. in December of 2013 with her husband.

"At the stage that I am, a lot of people are not even talking. A lot of people are on feeding tubes," said Debra.

So, she and her husband, who has since reached out to friends in football and acting, have been using their voices to spread awareness about the physical, emotional and financial impact of the debilitating, neurodegenerative disease.

"If I can be a voice to someone else's mother, father, sister, or brother that has Lou Gehrig's Disease, Debra's Journey For Life Foundation is going to lift them up, and let them know there is a source of help," said Walter.

"There is no selfishness to Debra at all. It involves her, but it's bigger than her," said Steve Pisarkiewicz, Debra's Journey For Life Foundation Board Chairman, who is also a former NFL player and leader of the local NFL player's association.

"The clock is running. Lets go," said Steve, about the couple's desire for public support so that they may travel abroad for a stem cell treatment. He also claims it is time to invest in finding treatments and a cure through research which is a top priority of the ALS Association that is behind last summer's ice bucket challenge.

See the original post:
Orlando family impacted by ALS asks for support

Collaborating with scientists from New York, Toronto, and Tokyo, Harvard Stem Cell Institute (HSCI) researchers have devised two methods for using stem cells to generate the type of neurons that help regulate behavioral and basic physiological functions in the human body, such as obesity and hypertension, as well as sleep, mood, and some social disorders.

The work by Florian Merkle, Kevin Eggan, Alex Schier, and colleagues provides researchers, for the first time, with live hypothalamic neurons to use as targets for drug discovery and therapeutic cell-transplantation efforts for conditions related to stress, reproduction, puberty, and immune function, as hypothalamic neurons are often involved in those diseases as well.

Not only is this exciting because of the science involved, said Merkle, a postdoctoral fellow in the lab of HSCI principal faculty member Kevin Eggan, who pioneered disease in a dish technology, but by being able to produce this one type of neuron we bring possible treatments for a wide range of conditions closer to the clinic.

The hypothalamus is an ancient structure of the brain, said Merkle. Its very conserved, and thats because it plays such a basic function. Though it makes up only about 0.3 percent of the adult human brain, the hypothalamus serves as a regulator for numerous basic physiological functions.

Thus far, research exploring the origin or process of hypothalamic dysfunction has been limited because researchers havent been able to observe live hypothalamic cells.

Merkle and a team of scientists from HSCI, New Yorks Sloan Kettering Institute for Cancer Research, Torontos Hospital for Sick Children, and Japans RIKEN developed the two neuron-generating methods, self-patterning and directed differentiation, concurrently.

The new work has been published in the journal Development.

In his self-patterning approach, Merkle put 5,000 stem cells in a dish amid an environment conducive to survival and left them alone. Within a day, the cells would aggregate and communicate with each other to plan which stem cells would differentiate into which neural progenitors. The aggregate eventually differentiated into cells that, together, made a tissue-like structure similar to the hypothalamus.

When asked how the two processes differed, Merkle said that during directed differentiation the researchers are pushing [stem] cells very strongly, guiding them toward a particular fate, and not relying on them to do it themselves. Merkle used small molecules to steer stem cell differentiation down a specific pathway.

I think that there is definitely more opportunity to explore and refine directed differentiation to make different regions within the hypothalamus, said Merkle.

See the article here:
A new stem cell advance | Harvard Gazette

Miami, FL (PRWEB) March 03, 2015

GlobalStemCellsGroup.com has recruited Mario Camacho Alcocer to the companys growing faculty. Camacho Alcocer, a biomedical researcher and founding partner of Criogenix SA de CV in Queretaro, Mexico, will join GSCGs team of biomedical professors who will teach the Diplomat in Cell Therapy and Tissue Engineering program.

Criogenix SA de CV is a private company registered in the National Record of Scientific and Technological Institutions and Companies in Mexico (RENIECYT).

Camacho Alcocer will teach two-day, interactive training courses on adult stem cell extraction and re-integration to physicians and qualified medical practitioners who wish to learn and use the process in their practices.

Camacho Alcocer is accomplished in generating and applying new stem cell therapeutic protocols and technologies. His current research focuses on extracellular matrix interactions to regulate the dynamic of defined stem cells populations, with a goal to regenerate functional capabilities of specific tissues (or to develop tissues in vitro), as well as the development of specific scaffolds for cell culture. His research is central to Criogenix SA de CVs development of a major integral stem cell unit management system for therapeutic applications.

Global Stem Cells Group and Regenestem Network are expanding the companys clinical presence worldwide by partnering with experienced and qualified regenerative medicine physicians to open new clinics licensed and developed under the Regenestem banner.

In 2014, Global Stem Cells Group expanded its Regenestem Networks global presence to 20 countries. Regenestem offers stem cell treatments to help treat a variety of diseases and conditions including arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes, and pain due to injuries at various facilities worldwide.

Regenestem is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. Regenestem clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.

The Global Stem Cells Group is committed to the highest standards in service and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.

For more information, visit the Global Stem Cells Group website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.

Original post:
Mario Camacho Alcocer Joins Global Stem Cells Group Faculty

CALGARY They call it the miracle of stem cells and it was nothing less than a miracle says Marty Howe about his dad Gordies recovery.

Ata press conference Tuesday in Calgary for the Gordie Howe C.A.R.E.S annual hockey Pro-AM, Marty Howe talked about how the stem cell treatment saved Gordie Howes life after suffering two strokes.

He probably had a month to live the way he was going, he was deteriorating pretty fast. To have him now back and be able to relate to everybody really helps, Marty Howe said.

The Howe family remains positive and believes Gordie might be able to travel again and attend events soon. Marty Howe said his dad is already planning to attend an event in Saskatoon next month.

He can walk, hes got a sense of freedom now. He can play with the grand kids. He still needs to work with his speech, he cant sign yet but hopefully in the future he will be able to, Howe said.

Its a joy to have him with us still. Its nothing more of a gift. Hes down in Texas with my sister and we have caregivers that have been coming in for the past two and a half years too.

Gordie Howe has aform of dementia and the 86-year-old suffered hismost recent stroke just before Christmas last year due to dehydration.

A group of doctors, who happened to be named Howe, contacted the family and told them about a stem cell treatment they could offer for Gordie Howe. So the family went down to Mexico to give it a try.

Gordies health improved dramatically. Soon after, hewas able to walk and speak again. The family says Gordie plans to do asecond treatment in two months.

Known as Mr. Hockey, Howe was the NHLs Most Valuable Player six times. He played on four Stanley Cup championship teams in Detroit during a 25-year stint that began in 1946. The league scoring records he set stood until Wayne Gretzky broke them.

Read the original post:
Gordie Howes health improved dramatically after stem cell treatment